Delivery Order SPE2DB22D3004-SPE2DB25FPS72
Award Date
2/27/25
Potential Completion Date
2/28/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract to provide PHENOBARBITAL 65 MG/ML VIALML, a pharmaceutical product, with a potential value of $1,334.21. The contract has a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not a set-aside contract. This delivery order is issued under an Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,292.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4564675568 – PHENOBARBITAL 130 MG/ML VIALML, with a performance period ending on May 22, 2024. This award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,172.43, is for the delivery of PHENOBARBITAL 130 MG/ML VIALML to support federal healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under Contract SPE2DX15D3026/SPE2DX24FUXDA with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,241.12, is for the supply of PHENOBARBITAL 65 MG/ML VIAL. This delivery order does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,924.30, is for the delivery of PHENOBARBITAL 65 MG/ML VIALML. The contract is a firm-fixed-price Delivery Order with an ultimate completion date of August 8, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The U.S. Defense Logistics Agency (DLA) awarded a $3,005.42 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 130 mg/mL vials of the drug Phenobarbital. The contract has a period of performance through February 20, 2025 and does not include any set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999...
This federal contract award, identified as SPE2DB20D7061|SPE2DB25FSMH4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,095.09, is a Delivery Order for the supply of PHENOBARBITAL 130 MG/ML VIALML. The contract does not have a set-aside designation, indicating it was awarded through open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Phenobarbital 130 mg/ml vials. The contract is a Delivery Order with a Firm Fixed Price of $7,906.95 and a period of performance ending on July 30, 2024. The contract does not have a set-aside designation. Amerisourcebergen, through its Corporate Office division, will provide these essential pharmaceutical products to support...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,938.32 fixed-price delivery order is for the supply of Phenobarbital 130 mg/mL vials. This award is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $1,065.20 firm-fixed-price delivery order is for the supply of Phenobarbital 130 mg/mL solution, a critical medication, to support federal healthcare programs and military treatment facilities. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that...